Evidence map›Paper›PMID 33435896›Full record

ArticleBMC infectious diseases2021

Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.

Lydia Nakiyingi, John Mark Bwanika, Willy Ssengooba, Frank Mubiru, Damalie Nakanjako, Moses L Joloba, Harriet Mayanja-Kizza, Yukari C Manabe

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Machine learning analysis of SERS fingerprinting for the rapid determination ofComputational and structural biotechnology journal · 2022
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Lydia NakiyingiResearch Department, Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda. Lydiakiyingi@gmail.com.ORCID http://orcid.org/0000-0001-7263-3198
John Mark BwanikaResearch Department, Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
Willy SsengoobaDepartment of Medical Microbiology and Immunology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda.
Frank MubiruResearch Department, Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
Damalie NakanjakoDepartment of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Moses L JolobaDepartment of Medical Microbiology and Immunology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda.
Harriet Mayanja-KizzaDepartment of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Yukari C ManabeJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Makerere University · UGInfectious Diseases Institute · UGJohns Hopkins University · US

Funding

NURTURE:Research Training and Mentoring Program for Career Development of Faculty at Makerere University College of Health SciencesD43TW010132 · FIC · MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES · PI SEWANKAMBO, NELSON K · 2015 to 2019
$4.3M
HIV Co-infections in Uganda: TB, Cryptococcus, and Viral Hepatitis.D43TW009771 · FIC · JOHNS HOPKINS UNIVERSITY · PI CASTELNUOVO, BARBARA, KAMBUGU, ANDREW DDUNGU · 2014 to 2023
$3.3M
FIC NIH HHS D43 TW009771FIC NIH HHS D43 TW010132Foundation for the National Institutes of Health D43TW009771Foundation for the National Institutes of Health D43TW010132Foundation for the National Institutes of Health HHSN2722000900050CNIAID NIH HHS HHSN272200900050CWellcome TrustWellcome Trust 107743/z/15/z
6 · The paper itself

Abstract

backgroundChest X-ray (CXR) interpretation remains a central component of the current World Health Organization recommendations as an adjuvant test in diagnosis of smear-negative tuberculosis (TB). With its low specificity, high maintenance and operational costs, utility of CXR in diagnosis of smear-negative TB in high HIV/TB burden settings in the Xpert MTB/RIF era remains unpredictable. We evaluated accuracy and additive value of CXR to Xpert MTB/RIF in the diagnosis of TB among HIV-positive smear-negative presumptive TB patients.

methodsHIV co-infected presumptive TB patients were recruited from the Infectious Diseases Institute outpatient clinic and in-patient medical wards of Mulago Hospital, Uganda. CXR films were reviewed by two independent radiologists using a standardized evaluation form. CXR interpretation with regard to TB was either positive (consistent with TB) or negative (normal or unlikely TB). Sensitivity, specificity and predictive values of CXR and CXR combined with Xpert MTB/RIF for diagnosis of smear-negative TB in HIV-positive patients were calculated using sputum and/or blood mycobacterial culture as reference standard.

resultsThree hundred sixty-six HIV co-infected smear-negative participants (female, 63.4%; hospitalized, 68.3%) had technically interpretable CXR. Median (IQR) age was 32 (28-39) years and CD4 count 112 (23-308) cells/mm

conclusionIn this high prevalence TB/HIV setting, CXR interpretation added sensitivity to Xpert MTB/RIF test at the expense of specificity in the diagnosis of culture-positive TB in HIV-positive individuals presenting with TB symptoms and negative smear. CXR interpretation may not add diagnostic value in settings where Xpert MTB/RIF is available as a TB diagnostic tool.

Indexed as

AdultAIDS-Related Opportunistic InfectionsCD4 Lymphocyte CountCoinfectionData AccuracyFemaleHealth ResourcesHIVHumansMaleMass Chest X-RayMycobacterium tuberculosisNucleic Acid Amplification TechniquesSensitivity and SpecificitySputumTuberculosis, PulmonaryChest X-rayDiagnosisResource-limited settingSmear-negativesTuberculosis, HIVUganda

Identifiers

PMID33435896
PMCPMC7805204
OpenAlexW3119639047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.